Heart, Lung and Circulation
Volume 18, Issue 6 , Pages 388-392 , December 2009

The COACH Program Produces Sustained Improvements in Cardiovascular Risk Factors and Adherence to Recommended Medications—Two Years Follow-up

  • Michael Jelinek, MD

      Affiliations

    • Department of Medicine, The University of Melbourne, Australia
    • St.Vincent's Hospital, Melbourne, Australia
    • Corresponding Author InformationCorresponding author at: 55 Victoria Parade, Fitzroy 3065, Victoria, Australia. Tel.: +61 394170177; fax: +61 394170180.
  • ,
  • Margarite J. Vale, PhD

      Affiliations

    • Department of Medicine, The University of Melbourne, Australia
    • St.Vincent's Hospital, Melbourne, Australia
  • ,
  • Danny Liew, MBBS

      Affiliations

    • Department of Medicine, The University of Melbourne, Australia
    • St.Vincent's Hospital, Melbourne, Australia
  • ,
  • Leeanne Grigg, MBBS

      Affiliations

    • The Royal Melbourne Hospital, Australia
  • ,
  • Anthony Dart, BA BM BCh FRCP Dphil

      Affiliations

    • Alfred Hospital, Australia
  • ,
  • David L. Hare, MBBS

      Affiliations

    • Department of Medicine, The University of Melbourne, Australia
    • Austin and Repatriation Medical Centre, Australia
  • ,
  • James D. Best, MD

      Affiliations

    • Department of Medicine, The University of Melbourne, Australia
    • St.Vincent's Hospital, Melbourne, Australia

Received 25 March 2009 ,Revised 22 May 2009 ,Accepted 5 June 2009.

References 

  1. Bowker TJ, Clayton TC, Ingham J, McLennan JR, Hobson HL, Pyke SD, et al. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events). Heart. 1996;75:334–342
  2. Pearson TA, Peters TD. The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient. Am J Cardiol. 1997;80(8B):45H–52H
  3. Vale MJ, Jelinek MV, Best JD. How many patients with coronary heart disease are not achieving their risk factor targets? Experience in Victoria 1996–1998 versus 1999–2000. Med J Aust. 2002;176:211–215
  4. Kotseva K, Wood D, de Backer G, de Bacquer D, Pyorala K, Keil U. Cardiovascular prevention guidelines in daily practice: a comparison pf EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009;373:929–940
  5. Vale MJ, Jelinek MV, Best JD, Santamaria JD. Coaching patients with coronary heart disease to achieve the target cholesterol: a method to bridge the gap between evidence-based medicine and the ‘real world’. Randomized controlled trial. J Clin Epidemiol. 2002;55:245–252
  6. Vale MJ, Jelinek MV, Best JD, Dart AM, Grigg LE, Hare DL, et al. Coaching patients on achieving cardiovascular health (COACH). A multicentre randomised trail in patients with coronary heart disease. Arch Intern Med. 2003;163:2775–2783
  7. Redfern J, Briffa T, Ellis E, Freedman SB. Choice of secondary prevention improves risk factors after acute coronary syndrome: 1 year follow-up of the CHOICE (Choice of Health Options In Prevention of Cardiovascular Events) randomised controlled trial. Heart. 2009;95:468–475
  8. Reid C, Nelson MR, Shiel L, Chew D, Connor G, Delooze F. Australians at risk: management of cardiovascular risk factors in the REACH Registry. Heart Lung Circ. 2008;17:114–178
  9. Chew DP, Amerena JV, Coverdale SG, Rankin JM, Astley CM, Soman A, et al. Invasive management and late clinical outcomes in contemporary Australian management of acute coronary syndromes: observations from the ACACIA registry. MJA. 2008;188:691–697

PII: S1443-9506(09)00948-2

doi: 10.1016/j.hlc.2009.06.001

Heart, Lung and Circulation
Volume 18, Issue 6 , Pages 388-392 , December 2009